Stay updated on Glesatinib Combo With Nivolumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Glesatinib Combo With Nivolumab in NSCLC Clinical Trial page.

Latest updates to the Glesatinib Combo With Nivolumab in NSCLC Clinical Trial page
- Check2 days agoChange DetectedThe page revision label was updated from v3.6.4 to v3.6.5, indicating a new version of the page. This update reflects a version bump rather than changes to the study data.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedA new Publications section was added with a PubMed citation and a note that publications are auto-filled from PubMed; the revision version is updated to v3.6.4 (replacing the previous v3.6.3).SummaryDifference0.3%

- Check23 days agoNo Change Detected
- Check44 days agoChange DetectedThe page shows Revision: v3.6.3 instead of the previous v3.6.0. This indicates a minor platform update rather than changes to the study details.SummaryDifference0.0%

- Check59 days agoChange DetectedRecruitment status is updated to No longer looking for participants, indicating that the study is no longer seeking participants. The update also adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and standardizes the Intervention/Treatment heading (previously Intervention / Treatment).SummaryDifference0.4%

- Check66 days agoChange DetectedThe page revision tag was updated from v3.5.4 to v3.5.5, indicating a minor software release rather than a content change.SummaryDifference0.0%

- Check87 days agoChange DetectedThe page now shows the latest revision as v3.5.4, replacing the previous v3.5.3 in the revision history.SummaryDifference0.0%

Stay in the know with updates to Glesatinib Combo With Nivolumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Glesatinib Combo With Nivolumab in NSCLC Clinical Trial page.